stoxline Quote Chart Rank Option Currency Glossary
  
(CRDU)
  0 (0%)    07-17 22:13
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2026-07-17 4:43:02 PM
Short term     
Mid term     
Targets 6-month :  116.61 1-year :  148.19
Resists First :  99.84 Second :  126.87
Pivot price 89.13
Supports First :  56.09 Second :  46.67
MAs MA(5) :  83.95 MA(20) :  88.83
MA(100) :  49.89 MA(250) :  0
MACD MACD :  3 Signal :  4.9
%K %D K(14,3) :  31 D(3) :  28.5
RSI RSI(14): 50.7
52-week High :  126.87 Low :  12.86
Price, MAs and Bollinger Bands

Price has closed below its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and BULLISH in mid-long term.
[ CRDU ] has closed above bottom band by 37.9%. Bollinger Bands are 55.8% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 17 days. This is a sign that the current trend might continue.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 90.11 - 90.58 90.58 - 90.98
Low: 79.09 - 79.58 79.58 - 80
Close: 82.47 - 83.33 83.33 - 84.06
Company Description

Headline News

Mon, 13 Jul 2026
CRDU ETF Profile: Dividends, Returns (CBOE:CRDU) - TradingView

Wed, 17 Sep 2025
CRDU Stock Fund Price and Chart — CBOE:CRDU - TradingView

Tue, 16 Sep 2025
Tradr Launches First Mover Leveraged ETFs on CLSK, CRDO, ENPH, GS and U - PR Newswire

Tue, 16 Sep 2025
CRDU: Tradr 2X Long CRDO Daily ETF Latest Stock Price, Analysis, News and Trading Ideas - Stocktwits

Fri, 29 Aug 2025
Exploring Interstitial Pneumonia With Autoimmune Features: Case Study Insights and Review of Current Literature - Wiley Online Library

Wed, 14 Sep 2022
IgG4-related disease associated with the primary manifestation of recurrent cerebral venous thrombosis: A rare case report - Wiley Online Library

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Industry:
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android